ClinicalTrials.gov
ClinicalTrials.gov Menu

A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00724334
Recruitment Status : Completed
First Posted : July 29, 2008
Last Update Posted : March 17, 2016
Sponsor:
Information provided by (Responsible Party):
Sanofi

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2014
  Actual Study Completion Date : May 2014
  Certification/Extension First Submitted : February 17, 2016